Copyright
©The Author(s) 2022.
World J Psychiatry. Jul 19, 2022; 12(7): 944-957
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944
Published online Jul 19, 2022. doi: 10.5498/wjp.v12.i7.944
Table 2 Substance use in both groups
| Substance class | n | P | |
| MA-group | OS-group | ||
| Alcohol | 16 | 21 | 0.31 |
| Cannabis | 32 | 42 | 0.04 |
| Cocaine | 5 | 19 | 0.001 |
| Hallucinogens | 0 | 1 | 0.3 |
| Opioids | 3 | 7 | 0.18 |
| Sedativa | 2 | 3 | 0.65 |
| Tobacco | 49 | 42 | 0.07 |
| Volatile solvents | 1 | 0 | 0.3 |
| Stimulants | 55 (methamphetamine) | 31 (amphetamine) | - |
- Citation: Behle N, Kamp F, Proebstl L, Hager L, Riebschläger M, Schacht-Jablonowsky M, Hamdorf W, Neumann S, Krause D, Manz K, Franke AG, Koller G, Soyka M. Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users. World J Psychiatry 2022; 12(7): 944-957
- URL: https://www.wjgnet.com/2220-3206/full/v12/i7/944.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i7.944